| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V6861 | Eliglustat (GENZ-112638, Genz 99067, Cerdelga) | 491833-29-5 | Eliglustat (GENZ-112638, Genz-99067, GENZ112638, Genz99067,Cerdelga) is a novel, potent, specific and orally bioactive glucocerebroside synthase inhibitor (IC50= 24 nM) approved by FDA in 2014 for the treatment for Gauchers disease. |
|
V5886 | Eliglustat tartrate | 928659-70-5 | Eliglustattartrate (GENZ-112638; Genz-99067; Cerdelga), the tartrate salt of eliglustat, isa specific and orally bioactiveglucocerebroside synthaseinhibitor (IC50= 24 nM) that has been approved by the FDA in August 2014 for thetreatment for Gauchers disease type 1 (GD1). |